Rapid Review Quiz: Back Pain

Steven I. Rabin, MD


August 11, 2022

The study was presented as Treatment of Painful Lumbar Degenerative Disc Disease: A Feasibility Study with Hydrogel, by Dr Douglas P. Beall at the Annual Scientific Meeting of the Society of Interventional Radiology. In the study, patients with CLBP caused by degenerative disc disease received spinal disc injections with an experimental hydrogel. The study included 20 adults with moderate to severe CLBP caused by degenerative disc disease. Patients described their pain as 4 or higher on a 10-point scale, and none found more than mild relief from previous conservative care, which included analgesics, physical therapy, rest, and back braces. According to the presentation, the treatment was safe and led to a "67% reduction" in back pain during a 1-year follow-up. The team also found an 85% reduction in Oswestry Disability Index scores, which they characterized as a "substantial" improvement in functional capability.

Learn more about lumbar degenerative disc disease.

This Rapid Review Quiz was excerpted and adapted from the Medscape articles Injectable Gel Might Help Relieve Chronic Low-Back Pain Due to Degenerative Disc Disease; Lumbar Degenerative Disc Disease; Patellofemoral Joint Syndromes; Chronic Back Pain Could Be Behind Runners' Knee Problems; Therapeutic Exercise; Medical Cannabis May Cut Opioid Use for Back Pain, OA; Marijuana; and Mechanical Low Back Pain.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.